Boehringer Ingelheim RCV GmbH & Co KG

The Boehringer Ingelheim RCV is responsible for the human pharmaceuticals and animal health business in more than 30 countries from Estonia to Israel and from Switzerland to Russia. Moreover Vienna coordinates the clinical research activities in the whole region. The site is the global cancer research center and one of four centres devoted to biopharmaceutical research, development and production in the international group of companies.